Descriptive review of current practices and prognostic factors in patients with ovarian cancer treated by pressurized intraperitoneal aerosol chemotherapy (PIPAC): a multicentric, retrospective, cohort of 234 patients

Descriptive review of current practices and prognostic factors in patients with ovarian cancer treated by pressurized intraperitoneal aerosol chemotherapy (PIPAC): a multicentric, retrospective, cohort of 234 patients

IntroductionOvarian cancer (OC) is the primary cause of mortality in women diagnosed with gynecological cancer. Our study assessed pressurized intraperitoneal aerosol chemotherapy (PIPAC) as treatment for peritoneal surface metastases (PSM) from recurrent or progressive OC and conducted survival ana...

Full description

Bibliographic Details
Main Authors:	Amaniel Kefleyesus, Aditi Bhatt, Cecilia Escayola, Vladimir Khomyakov, Martin Hübner, Marc A. Reymond, René Thieme, Olivia Sgarbura, Wouter Willaert, Wim Ceelen, Andrea Di Giorgio, Giuseppe Vizzielli, Olivier Glehen, Manuela Robella, Naoual Bakrin
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-08-01
Series:	Frontiers in Oncology
Subjects:	peritoneal metastases ovarian cancer PIPAC prognostic factors platinum sensitivity
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1204886/full

Similar Items

Consensus statement for treatment protocols in pressurized intraperitoneal aerosol chemotherapy (PIPAC)
by: Sgarbura Olivia, et al.
Published: (2022-03-01)

Establishment of a rat ovarian peritoneal metastasis model to study pressurized intraperitoneal aerosol chemotherapy (PIPAC)
by: Leen Van de Sande, et al.
Published: (2019-05-01)

The ISSPP PIPAC database: design, process, access, and first interim analysis
by: Mortensen Michael Bau, et al.
Published: (2021-04-01)

PIPAC versus HIPEC: cisplatin spatial distribution and diffusion in a swine model
by: Axel Davigo, et al.
Published: (2020-01-01)

Second annual report from the ISSPP PIPAC database
by: Mortensen Michael Bau, et al.
Published: (2023-12-01)

Editorial: Management of peritoneal surface malignancies. (cytoreductive surgery, HIPEC, PIPAC, and beyond)
by: Amine Souadka, et al.
Published: (2024-03-01)

Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) for the treatment of malignant mesothelioma
by: Urs Giger-Pabst, et al.
Published: (2018-04-01)

The Feasibility of Pressurised Intraperitoneal Aerosolised Virotherapy (PIPAV) to Administer Oncolytic Adenoviruses
by: Sophia J. Tate, et al.
Published: (2021-11-01)

Phase I study of intraperitoneal aerosolized nanoparticle albumin based paclitaxel (NAB-PTX) for unresectable peritoneal metastases
by: Wim Ceelen, et al.
Published: (2022-08-01)

Can pressurised intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC-O+) be added to standard treatment for resectable high-risk gastric cancer patients? A study protocol
by: Reid Jessica L., et al.
Published: (2021-09-01)

Radiologist Checklist for Selecting Patients to Undergo PIPAC (Pressurized IntraPeritoneal Aerosol Chemotherapy)
by: Elena Rodolfino, et al.
Published: (2021-09-01)

The role of cytology in patients undergoing pressurized intraperitoneal aerosol chemotherapy (PIPAC) treatment for peritoneal carcinomatosis
by: Deban Mélina, et al.
Published: (2023-05-01)

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in multimodal therapy for patients with oligometastatic peritoneal gastric cancer: a randomized multicenter phase III trial PIPAC VEROne
by: Casella Francesco, et al.
Published: (2022-06-01)

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with cisplatin and doxorubicin in combination with FOLFOX chemotherapy as a first-line treatment for gastric cancer patients with peritoneal metastases: single-arm phase II study
by: Martynas Luksta, et al.
Published: (2023-10-01)

UK trial of pressurised intraperitoneal aerosolised chemotherapy (PIPAC) with oxaliplatin for colorectal cancer peritoneal metastases (NCT03868228)
by: Kyle Peter, et al.
Published: (2023-09-01)

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for rare gynecologic indications: peritoneal metastases from breast and endometrial cancer
by: Günther A. Rezniczek, et al.
Published: (2020-11-01)

Hyperthermic intracavitary nanoaerosol therapy (HINAT) as an improved approach for pressurised intraperitoneal aerosol chemotherapy (PIPAC): Technical description, experimental validation and first proof of concept
by: Daniel Göhler, et al.
Published: (2017-12-01)

Pressurized intra-peritoneal aerosol chemotherapy (PIPAC): increased intraperitoneal pressure does not affect distribution patterns but leads to deeper penetration depth of doxorubicin in a sheep model
by: Myriam Mimouni, et al.
Published: (2021-04-01)

Early postoperative outcomes of staging laparoscopy for peritoneal metastases with or without pressurized intra-peritoneal aerosol chemotherapy (PIPAC)
by: Hugo Teixeira Farinha, et al.
Published: (2022-03-01)

Perception, knowledge and protective practices for surgical staff handling antineoplastic drugs during HIPEC and PIPAC
by: Benoist Hubert, et al.
Published: (2022-04-01)

A severe oxaliplatin immune-induced syndrome after oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy (PIPAC)
by: Ezanno Anne-Cecile, et al.
Published: (2022-01-01)

What is long-term survival in patients with peritoneal metastasis from gastric, pancreatic, or colorectal cancer? A study of patients treated with systemic chemotherapy and pressurized intraperitoneal aerosol chemotherapy (PIPAC)
by: Kryh-Jensen Charlotte G., et al.
Published: (2023-12-01)

RNA expression profiling of peritoneal metastasis from pancreatic cancer treated with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC)
by: Detlefsen Sönke, et al.
Published: (2024-06-01)

Outcome of patients with peritoneal metastasis from ovarian cancer treated with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)
by: Foslund Ingrid Terese, et al.
Published: (2024-06-01)

Role of intraperitoneal chemotherapy in gastric cancer
by: Amir Parray, et al.
Published: (2021-03-01)

Pressurized intraperitoneal aerosolized chemotherapy (PIPAC) experience in patients with recurrent low grade serous ovarian carcinoma (LGSOC): sub-cohort report of phase 1 clinical trial
by: Brad Nakamura, et al.
Published: (2024-08-01)

Impact of Pressurized Intraperitoneal Aerosol Chemotherapy on Quality of Life and Symptoms in Patients with Peritoneal Carcinomatosis: A Retrospective Cohort Study
by: Hugo Teixeira Farinha, et al.
Published: (2017-01-01)

Importance of biopsy site selection for peritoneal regression grading score (PRGS) in peritoneal metastasis treated with repeated pressurized intraperitoneal aerosol chemotherapy (PIPAC)
by: Fallah Mojib, et al.
Published: (2022-05-01)

Combined Nabpaclitaxel pressurized intraPeritoneal aerosol chemotherapy with systemic Nabpaclitaxel-Gemcitabine chemotherapy for pancreatic cancer peritoneal metastases: protocol of single-arm, open-label, phase II trial (Nab-PIPAC trial)
by: Di Giorgio Andrea, et al.
Published: (2024-11-01)

Localized chemotherapy approaches and advanced drug delivery strategies: a step forward in the treatment of peritoneal carcinomatosis from ovarian cancer
by: Silvia Breusa, et al.
Published: (2023-05-01)

Is pressurized intraperitoneal aerosol chemotherapy safe and effective in the treatment of peritoneal metastases from pancreatic adenocarcinoma?
by: Krzysztof Smoluchowski, et al.
Published: (2020-09-01)

Albumin-based cancer therapeutics for intraperitoneal drug delivery: a review
by: Leen Van de Sande, et al.
Published: (2020-01-01)

Occupational Exposure during Intraperitoneal Pressurized Aerosol Chemotherapy Using Doxorubicin in a Pig Model
by: Wongeon Jung, et al.
Published: (2023-06-01)

Comparing the cytotoxicity of taurolidine, mitomycin C, and oxaliplatin on the proliferation of in vitro colon carcinoma cells following pressurized intra-peritoneal aerosol chemotherapy (PIPAC)
by: Justyna Schubert, et al.
Published: (2019-06-01)

Gastric Cancer With Peritoneal Metastasis—A Comprehensive Review of Current Intraperitoneal Treatment Modalities
by: Aruna Prabhu, et al.
Published: (2022-05-01)

Management of peritoneal surface metastases from colorectal cancer: Cytoreductive surgery, hyperthermic intraperitoneal chemotherapy, pressurized intraperitoneal chemotherapy, and beyond
by: Christopher W. Mangieri, et al.
Published: (2022-11-01)

Systematic hybrid laparoscopic and endovascular treatment of median arcuate ligament syndrome: A single-center experience
by: Michael Schneider, et al.
Published: (2023-04-01)

Optimization of intraperitoneal aerosolized drug delivery using computational fluid dynamics (CFD) modeling
by: Mohammad Rahimi-Gorji, et al.
Published: (2022-04-01)

Intraperitonealna aerosolna kemoterapija pod povišanim pritiskom
by: Erik Brecelj, et al.
Published: (2019-12-01)

Dynamic assessment of intraperitoneal aerosol chemotherapy under pressure impact on peritoneal carcinomatosis in ovarian cancer (immediate results)
by: A. S. Dzasokhov, et al.
Published: (2023-03-01)